Literature DB >> 18437020

Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report.

Kyu-Hyoung Lim1, Sunyoung Kim, Yoon-Su Lee, Ki Hwan Kim, Jinwon Kim, Ji young Rhee, Hye Jin Kim, Hyeon Gyu Yi, So Yeon Oh, Joo Han Lim, Sae-Won Han, Sangyoon Lee, Inho Kim, Sung-Soo Yoon, Seonyang Park, Byoung Kook Kim.   

Abstract

We describe a 37-yr-old man who developed central pontine myelinolysis (CPM) after allogeneic hematopoietic stem cell transplantation (HSCT) for acute lymphoblastic leukemia. After HSCT, desquamation developed on the whole body accompanied by hyperbilirubinemia. The liver biopsy of the patient indicated graft-versus-host disease- related liver disease, and the dose of methylprednisolone was increased. Then, the patient developed altered mentality with eye ball deviation to the left, for which electroencephalogram and magnetic resonance imaging (MRI) scans were done. Brain MRI scan demonstrated the imaging findings consistent with central pontine myelinolysis and extrapontine myelinolysis. He did not have any hyponatremia episode during hospitalization prior to the MRI scan. To the best of our knowledge, presentation of CPM after allogeneic HSCT is extremely rare in cases where patients have not exhibited any episodes of significant hyponatremia. We report a rare case in which hepatic dysfunction due to graft-versus-host disease has a strong association with CPM after HSCT.

Entities:  

Mesh:

Year:  2008        PMID: 18437020      PMCID: PMC2526450          DOI: 10.3346/jkms.2008.23.2.324

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  10 in total

Review 1.  A review of the causes of central pontine myelinosis: yet another apoptotic illness?

Authors:  H Ashrafian; P Davey
Journal:  Eur J Neurol       Date:  2001-03       Impact factor: 6.089

2.  Central pontine myelinolysis following bone marrow transplantation complicated by severe hepatic veno-occlusive disease.

Authors:  C Fraser; L Charnas; P Orchard
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

Review 3.  Central pontine myelinolysis.

Authors:  Christian Lampl; Kambiz Yazdi
Journal:  Eur Neurol       Date:  2002       Impact factor: 1.710

4.  Central pontine myelinolysis. Considerations on etiology, diagnosis, and treatment.

Authors:  B Messert; W W Orrison; M J Hawkins; C E Quaglieri
Journal:  Neurology       Date:  1979-02       Impact factor: 9.910

5.  Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation.

Authors:  J P Fryer; M V Fortier; P Metrakos; D J Verran; S K Asfar; D M Pelz; W J Wall; D R Grant; C N Ghent
Journal:  Transplantation       Date:  1996-02-27       Impact factor: 4.939

6.  Central pontine myelinolysis.

Authors:  W F McCormick; C M Danneel
Journal:  Arch Intern Med       Date:  1967-05

7.  Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up.

Authors:  D J Bronster; S Emre; P Boccagni; P A Sheiner; M E Schwartz; C M Miller
Journal:  Clin Transplant       Date:  2000-02       Impact factor: 2.863

8.  Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia.

Authors:  B I Karp; R Laureno
Journal:  Medicine (Baltimore)       Date:  1993-11       Impact factor: 1.889

Review 9.  Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management.

Authors:  N Singh; V L Yu; T Gayowski
Journal:  Medicine (Baltimore)       Date:  1994-03       Impact factor: 1.889

10.  Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.

Authors:  R H Sterns; J D Cappuccio; S M Silver; E P Cohen
Journal:  J Am Soc Nephrol       Date:  1994-02       Impact factor: 10.121

  10 in total
  1 in total

1.  The magnetic resonance spectroscopy findings of extrapontine myelinolysis in a patient with acute lymphoblastic leukemia.

Authors:  Hulya Aslan; Fuldem Y Donmez; O Koray Hekimoglu; Huseyin G Tore
Journal:  Neurol Sci       Date:  2011-08-16       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.